Please use this identifier to cite or link to this item:
Title: Candida albicans in cystic fibrosis: “Opening statements presented, let the trial begin”
Authors: Chotirmall, Sanjay Haresh
Keywords: Candida
Cystic Fibrosis
Issue Date: 2015
Source: Chotirmall, S. H. (2016). Candida albicans in cystic fibrosis: “Opening statements presented, let the trial begin”. Pediatric Pulmonology, 51(5), 445-446.
Series/Report no.: Pediatric Pulmonology
Abstract: Cystic fibrosis (CF) is a chronic destructive genetic disease resulting from dysfunction of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein that encodes an apically located chloride ion channel on the cellular epithelial surface. Within the lung, this causes mucociliary impairment and consequently an inability to mobilize secretions. The result is mucus trapping, bacterial colonization, recurrent exacerbations, persistent inflammation, structural bronchiectasis and death predominantly attributed to respiratory failure 1,2. Important advances in understanding disease pathogenesis, particularly on a molecular level, coupled with newer therapeutic approaches have increased the life expectancy for patients with CF (PWCF). Such positive change also brings new and previously unrecognized challenges in disease management. One such challenge remains understanding the role of fungal colonization and infection in PWCF.
ISSN: 8755-6863
DOI: 10.1002/ppul.23315
Rights: © 2015 Wiley Periodicals, Inc. This is the author created version of a work that has been peer reviewed and accepted for publication by Pediatric Pulmonology, Wiley Periodicals, Inc. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [].
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
Candida albicans in cystic fibrosis- Opening statements presented, let the trial begin.pdf190.21 kBAdobe PDFThumbnail

Citations 50

Updated on Jan 13, 2023

Web of ScienceTM
Citations 50

Updated on Jan 22, 2023

Page view(s) 50

Updated on Jan 29, 2023

Download(s) 50

Updated on Jan 29, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.